Pharmaceutical Technology

JUNE 23, 2025

Robert Barrie June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bayer’s Eylea is a heavyweight of the ophthalmic drug landscape, approved for a range of eye diseases. The biosimilar specialist’s stock has been falling over the past year, though the company did post strong Q1 2025 results earlier this year.

Biosimilars 52

Biosimilars Pharmaceutical Manufacturing Communication Hospitals 52

Pharmaceutical Technology

JUNE 26, 2025

Fi Forrest June 26, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Credit: Shutterstock AI is revolutionizing drug discovery with its ability to analyze vast datasets. It also identifies off-label usage patterns and relevant comorbidities that may influence therapeutic decisions. Front Genet. 2020 Jan 9;10:1243.

Compounding 69

Compounding Drug Development Communication Packaging 69

FDA Law Blog: Biosimilars

JUNE 18, 2025

Livornese — After teasing a new rapid review pilot program for the past few weeks, on June 17, 2025, FDA officially announced the Commissioner’s National Priority Voucher (“CNPV”) program to expedite new drug and biologic (but not device or drug-device combination product) reviews. Tobolowsky & Michelle L. Butler & Deborah L.

Communication 59

Communication Labelling Drug Development 59

Pharmaceutical Technology

JUNE 18, 2025

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The company is studying the therapy in the global Phase IIb PRIZM trial. Subjects who conclude the trial will be qualified for an open-label extension trial. Credit: Volha_R/Shutterstock. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Packaging Labelling 52

pharmaphorum

JULY 2, 2025

Explainability is also crucial, particularly for areas of drug development, where AI outputs must be effectively communicated to meet regulatory requirements and build trust among clinicians, regulators, and patients. AI technologies can enable companies to program, rather than write, submissions to health authorities.

52

52

Pharma Marketing Network

MAY 2, 2025

Healthcare professionals (HCPs), too, are inundated with branded communications. A trusted brand is one that delivers value beyond the product label. Patient-Centric Communication Todays healthcare audience expects to be spoken tonot talked at. It must be rooted in authenticity and clarity.

Communication 52

Communication Customer Service Labelling Pharmaceutical Companies 52

Putting Patients First Blog

APRIL 8, 2025

NHC Submits Comments on FDA Draft Guidance for AI/ML-Enabled Medical Devices (PDF) April 7, 2025 Dockets Management Staff U.S. 9 Labeling materials should describe how the technology works, its intended use, known limitations, and the circumstances under which human oversight is recommended.

Documentation 52

Documentation Labelling Communication 52

Big Molecule Watch

JANUARY 10, 2025

As 2025 begins, we would like to reflect on last years regulatory developments in the biologics and biosimilars space. pharmacies in 2023, and with the PBMs operating in a system from the drug private labeler all the way down to the pharmacy and health insurer. Here are some of the top regulatory developments from 2024.

Biosimilars 45

Biosimilars Drug Pricing Labelling Communication 45

Putting Patients First Blog

APRIL 7, 2025

NHC Submits Comments on FDA Draft Guidance on AI to Support Regulatory Decision-Making for Drugs/Biologics (PDF) April 7, 2025 Dockets Management Staff U.S. Sponsors must document how AI- generated safety signals are prioritized, validated, and communicated to regulators and health care providers.

Documentation 52

Documentation Communication Pharmaceutical Manufacturing Labelling 52

The Nontraditional Pharmacist

JULY 1, 2025

It’s 2025. And ultimately, it’s to ensure we get the data because the data are ultimately what turns into your FDA approved label and demonstrates what you need. So, good talking to you. Matt Paterini (01:21): No, we appreciate the time. And remember, COVID was in there too, right? So, we would have spoken in 2019.

Hospitals 52

Hospitals Packaging Documentation Biosimilars 52

FDA Law Blog: Biosimilars

SEPTEMBER 22, 2024

Corrections and Removals Under 21 CFR Part 806, manufacturers generally need to communicate corrections and removals (i.e., Stage 1 is scheduled to take effect on May 6, 2025. FDA plans to hold its next webinar on September 24, 2024, which will cover the labeling requirements that go into effect in Stage 2.

Labelling 64

Labelling Communication 64

Pharmaceutical Technology

JUNE 27, 2025

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. The regulatory agency has also given approval to the removal of the REMS requirement from the product labels.

Labelling 52

Labelling Packaging Communication Hospitals 52

Pharmaceutical Technology

DECEMBER 22, 2022

The new joint procedure will launch in Q1 2025 for oncology medicines and other advanced therapy medicinal products and extend to orphan drugs in 2028. However, he did point out that the joint assessment could be a useful way of narrowing down typically broad EMA label content to specific patient populations.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52

Pharmaceutical Technology

JUNE 13, 2025

June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The approval marks AbbVie’s therapy as the first and only DAA treatment approved for this patient group. Credit: © AbbVie Inc. All rights reserved. ” Mavyret had also secured a breakthrough therapy designation from the US regulator for acute HCV.

Labelling 52

Labelling Communication Hospitals Vaccines 52

Putting Patients First Blog

JANUARY 27, 2025

3 ,4, 5 As such, the NHC supports CMS proposal to ensure that Part D sponsors cover AOMs for obesity with clinical criteria that is not more restrictive than the FDA labeling for each AOM. Comprehensive Transparency: AI applications should be fully disclosed, explainable, and accessible to patients and providers in layperson terms.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Pharmaceutical Technology

JUNE 30, 2025

Robert Barrie June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook CAR-Ts, the first of which were initially approved in June 2025, have demonstrated a wealth of efficacy in haematological oncology indications. The agency said that safety information can be adequately conveyed using drug product labelling.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Packaging Labelling Communication 52

Pharmaceutical Technology

JUNE 16, 2025

GlobalData Healthcare June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Surovatamig’s global sales are projected to reach $138 million by 2031. GlobalData Healthcare June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Surovatamig’s global sales are projected to reach $138 million by 2031.

Labelling 52

Labelling Communication Hospitals Vaccines 52

Pharmacy Times

JUNE 20, 2025

There are too many drug approvals, label updates, and new data published for even the most skilled and experienced oncology pharmacist to keep up with, let alone those still building their baseline knowledge. Accessed May 15, 2025. Accessed May 15, 2025. Accessed May 15, 2025. Accessed May 15, 2025. August 8, 2024.

Pharmacy Technician 42

Pharmacy Technician Compounding Compounding Pharmacies Biosimilars 42

Pharmaceutical Technology

JUNE 30, 2025

June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The acquisition will provide Torrent with access to a fast-growing Indian franchise and new therapeutic areas such as ophthalmology. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Communication Hospitals Drug Pricing 52

Pharmaceutical Technology

JUNE 30, 2025

June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Bird’s-eye view of the current Vetter site in Des Plaines where the clinical manufacturing facility will be built. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 52

Packaging Hospitals Compounding Communication 52

Pharmacy Times

JUNE 20, 2025

In general, choosing a product that has broad spectrum on the label, covering both UV-A and UV-B rays and containing 20% zinc oxide, for her children will be optimal, especially for more sensitive areas of the skin. Accessed May 12, 2025. Accessed May 12, 2025. Accessed May 12, 2025. Accessed May 12, 2025.

Pharmacy Technician 39

Pharmacy Technician Compounding Pharmacies Pharmacy Management Immunity 39

FDA Law Blog: Biosimilars

JULY 7, 2024

The first phaseout milestone is less than a year away; by May 6, 2025 most laboratories will need to demonstrate compliance with Medical Device Reporting (21 C.F.R. § 11] In the context of an LDT, it is unclear what FDA will include within the scope of “labeling” and what types of communications will be considered “claims.”

Labelling 64

Labelling Communication Documentation 64

Pharmaceutical Technology

JUNE 30, 2025

Robert Barrie June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook While zoonotic origin is the most likely source of the virus, a report says a definitive conclusion is not possible. How will RFK Jr’s American dream for vaccines play out? Give your business an edge with our leading industry insights.

Packaging 71

Packaging Communication Hospitals Vaccines 71

FDA Law Blog: Biosimilars

JULY 9, 2024

If FDA determines that a waiver will be issued, it may consider public communications about the decision. Since it is only the submission of the plan that is required by law, how, if at all, will FDA communicate that a plan does not meet the requirements for submission? Some unanswered questions remain.

Drug Development 59

Drug Development Communication Documentation Labelling 59

Pharmaceutical Technology

JUNE 16, 2025

Robert Barrie June 16, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Elevidys is the only gene therapy approved in US for DMD. By GlobalData Learn more about Strategic Intelligence Corwin added that Elevidys’s label will likely be updated to reflect the risk of ALF. Dragon Claws via Shutterstock.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Communication Hospitals Vaccines 98

PharmaTech

JUNE 12, 2025

Image Credit: © Tada Images - stock.adobe.com In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which stores more than 3400 such letters dating back to 2020 (1). American Behavioral Research Institute Boca Raton, Fla. –

Dosage 59

Dosage Drug Development Labelling Compounding 59

ID Stewardship

DECEMBER 11, 2024

With Twitter changing to X in mid-2023 and subsequently in the end of 2024 many folks from the IDtwitter community moving over to Bluesky, the game is certainly ever-changing. I wonder if this will cause us to be more fragmented as a group in 2025 and if Bluesky will really have sticking power. Mastodon sure did not.

HIV Treatment and Prevention Agents 145

HIV Treatment and Prevention Agents Labelling Hospitals Communication 145

Pharmaceutical Technology

JUNE 13, 2025

Robert Barrie June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook mRESVIA is the second approved product in the US for Moderna, along with its Covid-19 vaccine Spikevax. This usually begins around November and peaks in the mid-Winter months. Give your business an edge with our leading industry insights.

Vaccines 52

Vaccines Insurance Coverage and Processing Labelling Communication 52

FDA Law Blog: Biosimilars

MARCH 30, 2025

Livornese & Ricardo Carvajal On March 18, 2025, the U.S. Encouraging Transparency : FDA is working closely with manufacturers to ensure clearer labeling and increased transparency regarding ingredients and nutritional information on formula packaging. By Charles D. Snow & Deborah L.

Packaging 59

Packaging Labelling Communication 59

Pharmaceutical Technology

JUNE 6, 2025

Robert Barrie June 6, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook NHS England estimates that nearly 2.5 Figures published in May 2025 by NHS England estimated there were nearly 2.5 Originally approved for children in 2021, the FDA updated the drug’s label in January this year to include adults.

Communication 52

Communication Hospitals Drug Pricing Packaging 52

Pharmacy Times

JUNE 5, 2025

Detect-A-Dose lid-label cover enhances medication recognition, reducing packaging errors through a contrasting visual pattern. 1-3 Detect-A-Dose Lid Label Covers. 4 Detect-A-Dose features a contrasting black and white pattern on the underside of its label to make missing doses for patients apparent to pharmacists. REFERENCES 1.

Pharmacy Technician 26

Pharmacy Technician Packaging Labelling Immunity 26

FDA Law Blog: Biosimilars

FEBRUARY 5, 2025

Labeling Labeling Section VII Risk Assessment Risk Management File of Software Documentation Section VIII Data Management Data for development: Software Description of Software Documentation Data for testing: Performance Testing Section IX Model Description and Development Software Description Section X.A

Documentation 95

Documentation Labelling Communication 95

FDA Law Blog: Biosimilars

FEBRUARY 20, 2025

On February 19, 2025, Judge Sean Jordan in the Eastern District of Texas heard oral arguments in American Clinical Laboratory Association (ACLA) and the Association for Molecular Pathologys (AMP) [1] lawsuit against the Department of Health and Human Services. By Allyson B. Mullen & Jeffrey N.

Labelling 102

Labelling Communication 102

FDA Law Blog: Biosimilars

MAY 13, 2025

Section 5 of the May 12 EO states that within 30 days, HHS will communicate MFN price targets to pharmaceutical manufacturers to bring prices for patients in line with comparably developed nations. (We note our departure from more light-hearted content and absence of musical references. Please bear with us.)

Online Pharmacies 59

Online Pharmacies Drug Pricing Documentation Pharmaceutical Manufacturing 59

Pharmaceutical Technology

JUNE 30, 2025

Miranda McLaren June 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook When Donald Trump was elected the 47 th president of the United States of America, the outlook for pharmaceuticals was unclear, with 55% of North American industry professionals expecting negative repercussions when surveyed by GlobalData later that month.

Health and Personal Care Stores 52

Health and Personal Care Stores Packaging Drug Pricing Pharmaceutical Manufacturing 52